Trump Team Orders $16 Million in ICU Drugs for Virus Fight (1)

July 14, 2020, 4:00 PM UTCUpdated: July 14, 2020, 8:33 PM UTC

Fresenius Kabi and Baxter Healthcare Corp. will supply $16 million in vital ICU drugs to the national medical stockpile to bolster supplies for hospitals battling Covid-19.

The Strategic National Stockpile, a national repository of emergency medical supplies, is purchasing “critically needed ICU medications as part of the Covid-19 response” from Fresenius Kabi and Baxter Healthcare Corp. Fresenius was awarded a contract worth $12.5 million, and Baxter was awarded a contract worth $3.6 million.

Hospitals have struggled to get needed drugs during the pandemic and are looking at creating their own stockpiles of the medications.

The Department of Health and ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.